is tirzepatide good for prediabetes A 3-year study of in participants with obesity and showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 Tirzepatide (Mounjaro): Type 2 Diabetes

Subcutaneous BPC-157 (200 to 500 mcg, 1 to 2 times daily): Best for patients seeking systemic tissue repair, musculoskeletal recovery, or broad connective tissue support

Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations

The Fatty Liver Alliance gathered physician insights on metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), supplemented by a 2022 to 2023 US survey of patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis

3,6,7 Evidence supporting the use of cyclosporine and botulinum toxin A is limited, and currently neither of these treatment options is approved by the FDA

Adding sermorelin to testosterone replacement therapy (TRT) can provide synergistic benefits by enhancing growth hormone (GH) production, which naturally declines with age

Discussion Main findings In patients with T2DM and a low cardiovascular risk, first-line treatment with SGLT2i and GLP-1RAs led to significant reductions in HbA1c, body weight, and FPG levels